Sr. Director, Epidemiology
Johnson & Johnson
Ambler, United States
Dave Kern, PhD, MS is a Sr. Director of Epidemology at Johnson & Johnson. Dr. Kern heads the epidmiology teams supporting the Neuroscience therapeutic area and the Established Products group. Specific focuses include the disease areas of major depressive disorder, schizophrenia, ADHD, Alzheimer's disease and dementia. Additional interests include the exploration of unknown benefits of existing drugs and finding new uses for the mountains of existing data available to researchers.
Disclosure information not submitted.
Brain-penetrant calcium channel blockers for psychiatric use: revisiting the evidence for benefit
Tuesday, August 27, 2024
2:00 PM – 2:15 PM CEST